Physician profile
Alex C Moss
NPI 1437232659
$1,041.73
in general payments reported to CMS, 2019-2025
15 companies · $170 in 2025
The $170 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $268 · 2022: $403 · 2023: $90.61 · 2024: $110 · 2025: $170.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $370.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $370.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $504.13 | 2021-2025 | |
| Novartis Pharmaceuticals Corporation | $105.05 | 2024-2025 | |
| Novo Nordisk INC | $88.33 | 2022-2025 | Rybelsus, Ozempic |
| Astrazeneca Pharmaceuticals LP | $73.27 | 2021-2022 | |
| Abbott Laboratories | $41.19 | 2021-2022 | |
| Solventum Corporation | $36.63 | 2025 | Prevena |
| Pfizer INC. | $34.17 | 2021-2023 | |
| Lilly USA, LLC | $25.56 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $24.32 | 2021-2022 | |
| Amgen INC. | $23.52 | 2021 | |
| Astellas Pharma US INC | $21.24 | 2023 | Veozah |
| Biohaven Pharmaceutical Holding Company LTD. | $20.36 | 2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $18.05 | 2022 | |
| Beckman Coulter, INC. | $14.86 | 2023 | Dxh 900 Hematology System |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $11.05 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alex Moss listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.